Navigation Links
China Biologic Products Announces First Quarter 2008 Results Conference Call
Date:5/14/2008

TAI'AN CITY, Shandong, China, May 14 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP", "the Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that it will conduct a conference call at 5:00 p.m. Eastern Time on Thursday, May 15, 2008 to discuss the first quarter 2008 results.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 800- 688-0796. International callers should dial 617-614-4070. When prompted by the operator, mention Conference Passcode 991 762 11.

If you are unable to participate in the call at this time, a replay will be available for fourteen days starting on Thursday, May 15 at 7:00 p.m. Eastern Time. To access the replay, dial 888-286-8010, international callers should dial 617-801-6888, and enter the passcode 533 752 43.

About China Biologic Products, Inc.

China Biologic Products, Inc., through its indirect majority-owned subsidiary Shandong Taibang, is currently the only plasma-based biopharmaceutical company approved by the government of Shandong Province, the second largest province with a population of 93 million. The Company is engaged primarily in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Plasma-based Human Albumin is used mainly to increase blood volume while Immunoglobulin is used for disease prevention and treatment.

For more information please contact:

Company Contact:

Mr. Stanley Wong

CEO President

China Biologic Products, Inc.

Tel: +86-538-620-2306

Email: IR@chinabiologic.com

Website: http://www.chinabiologic.com

Investor Relations C
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... TAIPEI , Jan. 15, 2014 TaiGen Biotechnology ... an exclusive agreement with R-Pharm, a leading Russian pharmaceutical ... in the Russian Federation , ... Commonwealth Independent States (CIS). Nemonoxacin is a novel antibiotic for ...
(Date:1/14/2014)... Washington, DC (PRWEB) January 14, 2014 ... session for Thursday, January 23, 2014 at 2pm EST ... Actionable Knowledge.” The topic focuses on how technology can ... mission critical decisions for government agencies. The online webinar ...
(Date:1/14/2014)... leading provider of strategic communications services to corporations and organizations preparing ... the United States and Europe , ... returning to the firm,s Washington, D.C. office. ... two years of service as Associate Commissioner for the Office of ...
(Date:1/14/2014)... NY (PRWEB) January 14, 2014 EquitiesIQ, ... Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical ... serve the wound care market. , Free report download: ... restructured with a seasoned management team and Board, which ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... , , ... By Susan Catalano, Ph.D., Acumen Pharmaceuticals, Sylvia de Bruin, Joe Bosworth, ... Corporation, , 1311 Orleans Drive, Sunnyvale, CA 94089. , ... G-protein coupled receptors (GPCRs are the largest class of pharmaceutical ...
... and Ario de Marco , EMBL Protein Expression ... , Introduction ,Immobilized Metal ion Affinity ... that allows the fast separation of His-tagged proteins ... resins but all of them show some affinity ...
... , ,,Application Guide, ,I. Description ,II. Product ... User ,IV. Protocol for Extraction of DNA from ... from Plant ,VI. Quantification of Amplified Products ... References , Contact Information , , ,Application Guide, , ...
Cached Biology Technology:High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system 2High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system 3High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system 4High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system 5High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system 6High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system 7High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system 8High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system 9High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system 10High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system 11Double-Affinity Purification of GST-His Tagged Proteins Using Vivapure 8-to-96 Well Cobalt-Chelate Kit 2Double-Affinity Purification of GST-His Tagged Proteins Using Vivapure 8-to-96 Well Cobalt-Chelate Kit 3Double-Affinity Purification of GST-His Tagged Proteins Using Vivapure 8-to-96 Well Cobalt-Chelate Kit 4Protocol for GenomePlex Whole Genome Amplification from Plant 2Protocol for GenomePlex Whole Genome Amplification from Plant 3Protocol for GenomePlex Whole Genome Amplification from Plant 4Protocol for GenomePlex Whole Genome Amplification from Plant 5Protocol for GenomePlex Whole Genome Amplification from Plant 6
(Date:4/17/2014)... on a novel method to help kidney stone ... effective treatment possible., Kidney stones represent a major ... If left untreated, apart from being particularly painful, ... complications. In many patients treated successfully, stone recurrence ... pathological approach to diagnosis and treatment needs to ...
(Date:4/17/2014)... have detected new early-warning signs of the potential loss ... far-reaching implications for the diagnosis and treatment of diabetic ... Americans. , "We had not expected to see such ... said Ann Elsner, professor and associate dean in the ... study. "We set out to study the early signs, ...
(Date:4/17/2014)... immune system may fight cancers and viral infections. The ... treat illness. , The research, in mice, suggests that ... specialized squads of defenders that patrol only one ... the body. , Scientists at Washington University School of ... skin and uterus each has dedicated immune cells, which ...
Breaking Biology News(10 mins):New technique detects microscopic diabetes-related eye damage 2New technique detects microscopic diabetes-related eye damage 3Some immune cells defend only 1 organ 2
... in Plant Science Automated conserved ... promoter evolution among grasses Within the genome of ... undergo little change in position and sequence over millions of ... these evolutionarily stable sequences, so-called conserved noncoding sequences (CNSs), are ...
... Investigators at Rollins School of Public Health at Emory ... Technology, have received a $4 million grant over four ... (Health and Exposome Research Center: Understanding Lifetime Exposures). The ... the United States. The HERCULES Center is ...
... or harsh treatments because science fails to identify ... the disease. Researchers at Case Western Reserve University ... that allows patients to safely choose to do ... drastic measures. The project is one of ...
Cached Biology News:Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3
... Microarrays designed for genome-wide microRNA expression profiling ... Paraflo microfluidic on-chip synthesis platform. These microarrays ... microRNA Expression Profiling Service. Probe ... all known cow microRNAs (108 unique mature ...
... for genome-wide microRNA expression profiling and ... Paraflo microfluidic on-chip synthesis platform. These ... our comprehensive microRNA Expression Profiling Service. ... Viruses microRNA Microarray contains all known ...
...
... The Agilent 6850 Networked GC is an excellent ... footprint of a standard dual-channel GC, this one-channel ... GCs in the space of one. You get ... routine GC analyses in an instrument that has ...
Biology Products: